Pyridoxamine Attenuates PAH by Inhibiting the Receptor for Advanced Glycation end Products in Macrophages
Year: 2026
Type: article
Abstract: Background: The receptor for advanced glycation end products (RAGEs) and macrophage activation are involved in the pathophysiology of pulmonary artery hypertension (PAH).We hypothesized that activated macrophages could aggravate PAH through the inflammatory RAGE pathway and that pyridoxamine (PM) could attenuate PAH in monocrotaline-and Sugen 5416/hypoxia (SuHx)-induced PAH animal models.Methods: We evaluated the effect of PM on macrophage activation, inflammatory cytokine expression (interleukin [IL]-1β, IL-6, and tumor necrosis factor-α), RAGE and RAGE ligands (advanced glycation end products [AGEs], high motility group box 1 protein, and S100 calcium-
Source: Right Heart Journal
Institutions: Gachon University, Gachon University Gil Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7117989625
